Le Lézard
Classified in: Health
Subjects: SVY, AVO

Time to Kickstart the Conversation on Substance Use in Older Canadians


Key report from Canada's leading voice on substance use and addiction provides evidence-based knowledge for policy makers

OTTAWA, April 26, 2018 /CNW/ - As Canadian society ages, with adults 55 and over representing the fastest growing subgroup, the Canadian Centre on Substance Use and Addiction (CCSA) is announcing the release of Improving Quality of Life: Substance Use and Aging. This report, the latest in CCSA's Substance Use in Canada series, highlights the need to take the impacts of substance use and misuse into account when planning for the future of Canada's healthcare system and when addressing the needs of older adults.

"As a society, we need to start talking more about problematic substance use in older adults," said Rita Notarandrea, CCSA's CEO. "Much like youth, older adults experience significant physiological, psychological and social change. It's a period of rapid, dynamic and difficult transitions in life, and older Canadians can be especially vulnerable. Until now, there has been a lack of understanding of and research into this important segment of Canadian society, and our report is designed not only to close the knowledge gap, but also to support more effective prevention and intervention programs aimed at addressing substance use among older adults."

As the largest-growing segment of the population ages, so will the number of adults who use alcohol and other drugs. The metabolism of an older person is less capable of processing substances, and the negative effects of alcohol or other drug use can have real and lasting impacts on this segment of the population. This report from CCSA helps to fill the current gaps in knowledge and looks to contribute to healthy aging.

"There were two key questions that underpinned the research for this report," said Ms. Notarandrea: "How can we help people age in a healthy way? And how can we ensure they have the supports they need to sustain a good quality of life in their later years? These are the types of questions policy makers, legislators, public servants and healthcare professionals will need to answer as this demographic continues to grow. The expectation that the issue will become more prevalent in the coming years reinforces the need for action now."

Download a copy of Improving Quality of Life: Substance Use and Aging from the CCSA website.

About Canadian Centre on Substance Use and Addiction (CCSA)

CCSA was created by Parliament to provide national leadership to address substance use in Canada. A trusted counsel, we provide national guidance to decision makers by harnessing the power of research, curating knowledge and bringing together diverse perspectives.

CCSA activities and products are made possible through a financial contribution from Health Canada. The views of CCSA do not necessarily represent the views of the Government of Canada

SOURCE Canadian Centre on Substance Use and Addiction


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: